References

  1. The World Factbook CIA archive. Available at https://www.cia.gov/library/publications/the-world-factbook/. Accessed on May 16 2012.

  2. Infomédiaire. Available at www.infomediaire.ma. Accessed May 16 2012

  3. Aufait. Available at http://www.aufaitmaroc.com. Accessed May 16 2012

  4. Cherkaoui IJ, El Alaoui SC, Sbiti A et al. Consanguineous marriages in Morocco and the consequence for the incidence of autosomal recessive disorders. J Biosoc Sci. 2009;41(5): 575-81. This article on PubMed

  5. Chelli D, Dimassi K, Chaabouni M et al. Diagnostic anténatal de la trisomie 21 : expérience du service A du centre de maternité de Tunis. Cahiers Santé. 2008 ; 18:4

  6. Sherman SL, Allen EG, Bean LH, Freeman SB. Epidemiology of Down syndrome. Ment Retard Dev Disabil Res Rev. 2007;13:221-7. This article on PubMed

  7. Steele MW, et Breg WR. Chromosome analysis of human amniotic-fluid cells. Lancet. 1966;1:383-5. This article on PubMed

  8. Wyandt HE, Tonk VS, Huang XL et al. Correlation of abnormal rapid FISH and chromosome results from amniocytes for prenatal diagnosis. Fetal Diagn Ther. 2006;21:235-40. This article on PubMed

  9. Eiben B, Trawicki W, Hammans W, et al. A prospective comparative study on fluorescence in situ hybridization (FISH) of uncultured amniocytes and standard karyotype analysis. Prenat Diagn. 1998;18:901-906. This article on PubMed

  10. Ferguson SM, Aitken D, Arbuzova S, Benn P, Canick P, Cuckle H, et al. Down syndrome screening: a position statement from the scientific committee of the International Down Syndrome. Screening Group 2004. Available at http://www.leeds.ac.uk/idssg/position%20statement.htm. Accessed 16 May 2012

  11. American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 27: Clinical Management Guidelines for Obstetrician-Gynecologists. Prenatal diagnosis of fetal chromosomal abnormalities. Obstet Gynecol. 2001 May;97(5 Pt 1):suppl 1-12. This article on PubMed

  12. Anderson R et al. First trimester biochemical screening for trisomy 21: the role of free beta hCG, alpha fetoprotein and pregnancy associated plasma protein A. Ann Clin Biochem. 1994; 31:447-54. This article on PubMed

  13. Chelli D, Dimassi K et al. Diagnostic anténatal de la trisomie 21 : expérience du service A du centre de maternité de Tunis. Cahiers Santé. Octobre-novembre-décembre 2008; 18(4)

  14. SShawky RM, Zaky EA, El-Sobky ES et al. Prenatal diagnosis of aneuploidy among a sample of Egyptian high risk pregnancies. Egypt J Med Hum Genet. 2009 May; 10(1)

  15. Fauret AL, Bilan F, Patri S et al. Intérêt de la biologie moléculaire dans le diagnostic rapide de la trisomie 21 et des aneuploïdies les plus fréquentes. Gynécologie Obstétrique & Fertilité. 2009 ; 37:611-619

  16. Ogilvie CM, Lashwood A, Chitty L, Waters JJ et al. The future of prenatal diagnosis: rapid testing or full karyotype? An audit of chromosome abnormalities and pregnancy outcomes for women referred for Down’s Syndrome testing. BJOG. 2005; 112: 1369-75. This article on PubMed

  17. Schmidt W, Jenderny J et al. Detection of aneuploidy in chromosomes X, Y, 13, 18 and 21 by QF-PCR in 662 selected pregnancies at risk. Mol Hum Reprod. 2000; 6(9):855-60. This article on PubMed